HLS Therapeutics Inc. (HLS:CA) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-03-12 11:52:17 ET
HLS Therapeutics Inc. (HLS:CA) Q4 2025 Earnings Call March 12, 2026 8:30 AM EDT
Company Participants
Dave Mason - Investor Relations Officer
Craig Millian - CEO & Director
Brian Walsh - Chief Commercial Officer
John Hanna - CFO & Non-Independent Director
...
Read the full article on Seeking Alpha
For further details see:
HLS Therapeutics Inc. (HLS:CA) Q4 2025 Earnings Call Transcript
HLS Therapeutics Inc
NASDAQ: HLTRF
HLTRF Trading
0.0% G/L:
$3.44 Last:
100 Volume:
$3.44 Open:
HLTRF Latest News
HLTRF Stock Data
$103,778,594
19,614,853
N/A
2
N/A
Pharmaceuticals
Healthcare
CA
Etobicoke
